The rise of ADCs in oncology: how antibody drug conjugate therapies deliver precision
An antibody drug conjugate links a tumor-binding antibody to a potent small-molecule payload through a designed chemical linker. The aim…
An antibody drug conjugate links a tumor-binding antibody to a potent small-molecule payload through a designed chemical linker. The aim…
We spoke with Grace Breen, Senior Vice President, Quality at Sharp about the role of quality in a CDMO environment,…
The healthcare landscape has undergone a rapid transformation worldwide over the past decade. COVID-19 played a massive role in the…
Combining the specificity of monoclonal antibodies with the potency of cytotoxic payloads, ADCs enable targeted delivery of therapeutics to diseased…
Fast-track qualifications are becoming a popular option for people wanting to start “real life” faster. Compared to traditional degree programs,…
AI in clinical trials has the potential to offer faster insights, greater efficiency, and improved data quality. Nowhere is this…
While these transfers are a normal part of business, navigating them requires a strategic approach to ensure smooth and efficient…
Much larger than traditional small molecule drugs, peptides enable rapid tissue penetration while retaining the selectivity and potency of a…
The newest generation of AI-driven tools is beginning to reshape how clinical databases are built, governed, and maintained. This is…
Aseptic manufacturing plays a crucial role in the pharmaceutical supply chain, ensuring sterility for complex injectable biologics. In recent years,…